Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kinya Hatakeyama is active.

Publication


Featured researches published by Kinya Hatakeyama.


Pediatrics International | 2008

Increased serum high‐sensitivity C‐reactive protein is related to hypoxia and brain natriuretic peptide in congenital heart disease

Hideshi Tomita; Motoki Takamuro; Wataru Soda; Kinya Hatakeyama; Hiroyuki Tsutsumi

Background: Studies of adults have shown a direct association between increased serum concentrations of high‐sensitivity C‐reactive protein (hs‐CRP) and atherosclerotic cardiovascular disease, diabetes, and chronic heart failure. Some studies have documented elevated hs‐CRP in obese children and adolescents, and in patients with a history of Kawasaki disease, but there are few data on its clinical significance in congenital heart disease.


Journal of Cardiology | 2009

Coil occlusion of PDA in patients younger than 1 year: Risk factors for adverse events

Hideshi Tomita; Shigeru Uemura; Noriyuki Haneda; Takashi Soga; Takashi Matsuoka; Takashiro Nishioka; Satoshi Yazaki; Kinya Hatakeyama; Motoki Takamuro; Norihisa Horita

BACKGROUND Transcatheter occlusion of infantile patent ductus arteriosus (PDA) challenges the interventionist. PURPOSE To analyze the risk factors for adverse events from this procedure in patients younger than 12 months. SUBJECTS We retrospectively analyzed data on 32 patients younger than 12 months in whom transcatheter coil occlusion of a PDA was attempted. Ages ranged from 1 to 11 (median, 7) months and body weight from 1.2 to 10 (6.0) kg. The minimum ductal diameter ranged from 1.0 to 4.6 (3.3) mm and pulmonary to systemic flow ratio from 0.7 to 12.5 (2.2). Major adverse events were defined as those requiring surgery, while minor adverse events included transient hemolysis not needing treatment, coil migration with successful transcatheter retrieval, and mild left pulmonary artery (PA) stenosis. We determined whether any factors such as age, body weight, minimum PDA diameter, angiographic type, operator, and use of a 0.052-in. Gianturco coil related to the occurrence of adverse events. RESULTS In two patients, coils could not be deployed in the appropriate position. They underwent surgery following transcatheter retrieval of coils. Coils were successfully deployed in the other 30 patients, however, one patient developed persistent hemolysis that required surgical retrieval of the coils and closure. PDA was completely closed in the other 29 patients (clinical success rate, 91%). Thus, there were three major adverse events, while minor adverse events occurred in five patients. Univariate analysis did not identify any single factor that contributed to either major, minor, or total adverse events. However, all major adverse events occurred in patients under 6 months and less than 6 kg body weight with a minimum duct diameter of more than 3.5 mm. CONCLUSION Transcatheter coil occlusion of PDA is feasible in selected patients younger than 1 year. A minimum diameter more than 3.5 mm in patients under 6 kg may be a risk factor for major adverse events.


Japanese Circulation Journal-english Edition | 2000

Endothelialization of the Coils Used to Occlude a Persistent Ductus Arteriosus

Hideshi Tomita; Shigeto Fuse; Kinya Hatakeyama; Shunzo Chiba

To assess the endothelialization of the coils used to close a persistent ductus arteriosus (PDA), the present study comprised a review of the follow-up aortograms and pulmonary angiograms in 25 patients who underwent coil occlusion. The minimal diameter and the length of the PDA were measured prior to the procedure, and the shortest distance between the aortic end of the deployed coil and the aortic end of the PDA was measured after coil deployment. Evidence of endothelial coverage of the coil was sought on follow-up angiograms performed 6-24 (15+/-5) months later and the factors that determined the thickness of the endothelial coverage on the aortic end were investigated. Separation of the coil and the contrast column were detected at the aortic end in all cases and at the pulmonary end in 18 of 25 cases. The thickness of the separation ranged from 0.4 to 1.3 (0.7+/-0.2) mm at the aortic end and 0.3 to 0.8 (0.6+/-0.2) mm at the pulmonary end. The length of the ductus and of the ampulla had a significant positive correlation with the thickness of the aortic end separation. Apparent endothelial coverage of the coil was completed by 6 months after coil occlusion. Infective endocarditis or thromboembolism is an unlikely complication once endothelium covers the implanted coil.


Catheterization and Cardiovascular Interventions | 2003

Improvement of protein-losing enteropathy by coil embolization of the left azygos vein

Akira Ishii; Shigeto Fuse; Noriaki Kubo; Kinya Hatakeyama; Motoki Takamuro; Hideshi Tomita; Hiroyuki Tsutsumi

We report a 17‐year‐old boy with double‐outlet right ventricle, atrioventricular septal defect, pulmonary stenosis, and persistent left superior vena cava who developed a protein‐losing enteropathy, which was cured by coil embolization of the left azygos vein, thereby interrupting the vein‐to‐vein shunt. Cathet Cardiovasc Intervent 2003;59:399–401.


Journal of Cardiology | 2008

Genesis stent implantation without using a long sheath in two children

Toshiyuki Kobayashi; Hideshi Tomita; Masato Yokozawa; Motoki Takamuro; Kinya Hatakeyama; Sung-Hae Kim; Yasuo Ono; Kisaburo Sakamoto

A Genesis stent was implanted in two children, one with superior vena caval (SVC) stenosis and one with pulmonary artery branch stenosis. Case 1 was a 2-month-old baby with SVC stenosis following intracardiac repair for total anomalous pulmonary venous connection (TAPVC) and case 2 was a 2-year-old child with left lower pulmonary artery stenosis following one-stage unifocalization for dextrocardia, double outlet right ventricle, ventricular septal defect, pulmonary atresia and major aortopulmonary collateral arteries. Both procedures resulted in immediate clinical and hemodynamic improvement. The Genesis stent has a closed-cell design with sigma hinges interpositioned between each cell. With improved deliverability and expandability of the stent, we can easily deliver it through smaller sheaths, which will facilitate its use in infants and smaller children with vascular stenosis.


Journal of Medical Ultrasonics | 2016

Utility of three-dimensional transesophageal echocardiography for diagnosis of unroofed coronary sinus

Mina Kawamukai; Atsuko Muranaka; Satoshi Yuda; Yasumi Sato; Nobuko Makiguchi; Kazutoshi Tachibana; Kinya Hatakeyama; Nobuyuki Takagi; Tetsuya Higami; Tetsuji Miura

We report a case of unroofed coronary sinus (URCS) in a 42-year-old female. At an outpatient clinic, she was found to have an atrioventricular septal defect and mitral regurgitation with pulmonary hypertension, and she was transferred to our institute for surgical treatment. Both atrioventricular valves were located at the same level, and both the right atrium (RA) and right ventricle were enlarged on two-dimensional transthoracic echocardiography. Color Doppler imaging demonstrated severe mitral and tricuspid regurgitation and a left-to-right shunt from the left atrium (LA) to the RA. Although an ostium primum defect of the atrial septum was suspected, the exact position of the shunt flow was unclear. Two-dimensional transesophageal echocardiography (2D-TEE) could visualize a direct communication between the LA and coronary sinus. Three-dimensional transesophageal echocardiography (3D-TEE) clearly visualized the entire route from the coronary sinus into the LA and RA. The utility of 3D-TEE as a modality complementary to 2D-TEE in diagnosis of URCS was confirmed.


Cardiology in The Young | 2003

Acute recoil of stents used for the relief of stenotic great vessels in the setting of congenital cardiac disease

Hideshi Tomita; Satoshi Yazaki; Kohji Kimura; Ken Watanabe; Kinya Hatakeyama; Yasuo Ono; Shigeyuki Echigo

We implanted either large or medium Palmaz stents, or a Palmaz Corinthian stent, in various stenotic vessels, such as the pulmonary arteries, pulmonary veins, aorta, or superior caval vein. Using angiograms, we measured the diameter of the stenotic vessel before or after the implantation, the minimal diameter of the lumen, the minimal diameter of the largest fully expanded balloon used to expand the stent, and the diameter immediately after withdrawal of the balloon. The minimal diameter of the fully expanded balloon, and the minimal diameter of the lumen subsequent to expansion, were 8.2 +/- 2.4, and 7.7 +/- 2.3 mm, giving an absolute recoil of 0.5 +/- 0.4 mm, and a proportional recoil of 7 +/- 4%. There was no significant difference in either the absolute or proportional recoil for any of the stents, or for any of the different stenotic vessels. The proportional recoil correlated linearly with the minimal diameter of the lumen prior to the procedure, and with the ratio of the stenosis to the balloon, while the diameter of the stenotic vessels, the minimal diameter of the largest fully expanded balloon, the proportional stenosis prior to the procedure, and the ratio of the balloon to the diameter of the stenotic vessel, had no significant correlation with proportional recoil. The proportional recoil exceeded more than one-tenth when the minimal diameter of the lumen prior to the dilation was less than 3 mm, or the ratio of the balloon to the stenosis was greater than 3.0. An absolute recoil of around 1 mm is common when a large or medium Palmaz, or a Palmaz Corinthian stent, is implanted in great vessels. Balloons with a diameter of approximately one-tenth greater than that of the adjacent vessel may be needed if the minimal diameter of the lumen is small prior to the procedure.


Circulation | 2006

Coil Occlusion of Patent Ductus Arteriosus

Hideshi Tomita; Motoki Takamuro; Shigeto Fuse; Norihisa Horita; Kinya Hatakeyama; Hiroyuki Tsutsumi; Satoshi Yazaki; Shigeyuki Echigo; Kohji Kimura


Journal of Cardiology | 2007

Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report.

Hideshi Tomita; Kinya Hatakeyama; Wataru Soda; Toshiyuki Kobayashi


Pediatric Cardiology | 2003

Jarcho-levin syndrome associated with a complex congenital heart anomaly.

Kinya Hatakeyama; Shigeto Fuse; Hideshi Tomita; Susumu Chiba

Collaboration


Dive into the Kinya Hatakeyama's collaboration.

Top Co-Authors

Avatar

Hideshi Tomita

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Shigeto Fuse

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiroyuki Tsutsumi

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Motoki Takamuro

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Norihisa Horita

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Motoki Takamuro

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wataru Soda

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Nobuyuki Takagi

Sapporo Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge